Search Results (1,330)

Interest in phytotherapy and phytogenic additives in veterinary medicine and animal production has increased considerably, driven by the search for functional alternatives to extensive antimicrobial use and the growing emphasis on food safety. In this context, Curcuma longa L. and its main bioactive compound, curcumin, have attracted attention because of their antioxidant, anti-inflammatory, immunomodulatory and antimicrobial properties. This review synthesizes recent evidence on the use of C. longa and curcumin in veterinary medicine, with emphasis on the botanical and phytochemical basis of the plant, the main biological mechanisms involved, and reported applications in poultry, swine, ruminants, aquaculture, and companion animals. It further highlights that the interpretation of findings is strongly influenced by botanical identity, phytochemical variability, product type, standardization, dose and route of administration. Available evidence indicates promising effects on antioxidant status, intestinal health, productive performance and hepatic protection in selected experimental models. However, translation into practice remains constrained by the low oral bioavailability of curcumin, formulation heterogeneity and inconsistent reporting. Overall, C. longa represents a promising phytogenic resource, but robust veterinary recommendations require studies in target species, better characterized products and standardized experimental protocols for application. Full article

Background: Effective vaccines are essential to overcome the limitations of livestock immunisation, particularly in low- and middle-income countries (LMICs), where scalable, thermostable, and easy-to-administer solutions are needed. Nanoparticle-based delivery systems, such as the Spontaneous Nanoliposome Antigen Particle (SNAP) technology using CoPoP liposomes, offer a promising alternative for subunit vaccine development, although their performance in large animal species remains poorly characterised. CoPoP enables the rapid non-covalent multimeric display of His-tagged protein antigens combined with immunomodulators on liposomes incorporating cobalt porphyrin–phospholipid (CoPoP). Objective: To evaluate the immunogenicity of CoPoP-based liposomes delivering the Theileria parva p67C antigen in cattle and compare their performance in murine models. Methods: Cattle and mice were immunised with p67C formulated in CoPoP liposomes incorporating QS-21 and/or PHAD immunomodulators. Humoral and cellular responses were assessed. Parallel in vitro stimulation of bovine PBMC with Quil-A was used to investigate the mechanistic effects of saponins on bovine cells. Results: CoPoP liposome formulations did not improve p67C immunogenicity in cattle, with antibody responses at least two-fold lower than previously reported results and no detectable cellular responses. In contrast, the same platform induced up to 2000-fold higher antibody titres in mice. This disparity is likely driven by differences in antigen dose relative to body mass, tissue architecture, lymphatic accessibility, and innate immune signalling differences. PHAD-mediated TLR4 activation appeared less effective in cattle, whereas QS-21 induced a broader immune activation, likely through conserved inflammasome pathways. Despite limited immunogenicity, antigen presentation by CoPoP liposomes was preserved. Conclusions: SNAP-based CoPoP liposomes showed strong immunogenicity in mice but limited efficacy in cattle, highlighting the challenges of cross-species translation. Optimisation of antigen dose and adjuvant selection for the targeted species is required, with QS-21 representing a more promising candidate than the TLR4 agonist. The scalability and versatility of SNAP technology support its continued development for multivalent livestock vaccines. Full article

Background/objective: Approximately 90% of breast cancer-related deaths result from recurrence and metastasis. Emerging evidence indicates that tumor recurrence, invasion, and metastatic spread are strongly influenced by both the tumor microenvironment (TME) and the metastatic niche. M2 macrophages promote immune suppression, inhibit inflammation, and facilitate epithelial-to-mesenchymal transition, invasion, neovascularization, and tumor progression. These phenomena are particularly pronounced in triple-negative breast cancer (TNBC). The objectives of this study were to develop engineered exosomes to selectively deplete CD206+ M2 macrophages from the TME to delay the growth of primary tumors and distal metastasis and enhance overall survival. Methods: Engineered exosomes were developed using our invented platform to selectively target and deplete alternatively activated CD206+ M2 macrophages in primary and metastatic TMEs via antibody-dependent cell-mediated cytotoxicity (ADCC). The engineered exosomes were characterized for size, zeta potential, and successful incorporation of targeting peptides and proteins. Whole-body and tumor-specific biodistribution were assessed. In vitro and in vivo experiments were conducted to evaluate targeting specificity. Toxicity and immunogenicity were examined in immunocompetent animal models. Two treatment paradigms were employed. Results: Engineered exosomes containing M2 macrophage-targeting peptides and Fc-mIgG2b were successfully made, and no significant size difference was observed between the engineered and control exosomes. Both in vitro and in vivo studies confirmed the specificity of the engineered exosomes. Biodistribution studies showed no significant uptake or retention by the resident macrophages in the lung and liver. No significant immune activation, based on cytokine profiling, or organ-specific toxicity was observed in immunocompetent models. Flow cytometry studies using splenocytes showed significant depletion of M2 macrophages following treatments with engineered exosomes; however, no effect on the distribution of T cells was observed. M2-targeting engineered exosomes significantly delayed the post-resection recurrence and metastasis of tumors, and improved animal survival. Conclusions: These findings support the potential of precision exosome-based strategies for enhancing therapeutic outcomes in breast cancer. Full article

Development of innovative functional foods is a key sports nutrition strategy to enhance physical performance, support recovery, and promote overall health. Plant-based protein-rich products have emerged as a sustainable alternative to conventional animal-protein sources, offering nutritional benefits and reducing environmental impact. This study aimed to develop high-protein plant-based cookies using a conventional formulation enriched with carrot, broccoli, and legume flour, and to evaluate their effects in a preclinical model. The nutritional composition was determined using standard food analysis methods and microbiological assays were conducted to ensure safety. Twelve-week-old male Wistar rats were randomly assigned to either a standard diet group or a cookie-supplemented group. The intervention consisted of daily administration of cookies at a dose of 5.3 g/kg body weight for 15 days. Physiological and biochemical parameters, including body weight, glucose, lipid profile, renal function, muscle thickness, and grip strength, were assessed. Despite no significant differences in glucose and lipid profiles between groups, increased muscle thickness (pubococcygeus and gastrocnemius), improved grip strength and higher levels of urea and creatinine were observed in the supplemented group. These findings indicate that high-protein plant-based cookies are safe in preclinical conditions and may promote functional benefits such as enhanced muscle strength and lean mass development. Therefore, they represent a promising and sustainable functional food for sports nutrition applications. Full article

Capsaicin has been investigated as a phytogenic feed additive in animal production due to reported growth-promoting and immunomodulatory properties; however, its pungency limits practical application. Capsiate, a naturally occurring non-pungent capsaicin analog present in specific Capsicum annuum accessions, conserves many of its bioactive properties without inducing sensory irritation and has not been studied as a potential growth-promoting alternative. The present study evaluated whether dietary exposure to a capsiate-producing chili pepper influences growth and assessed associated intestinal responses using a murine model. A capsiate-producing Capsicum annuum accession (509-45-1) was characterized and incorporated into experimental diets providing 30 or 50 mg/kg capsiate to male C57BL/6J mice for 12 weeks. The dietary intervention was associated with dose-dependent increases in body weight and longitudinal femoral growth without altering body composition. Femoral elongation was accompanied by increased growth plate area and higher osteocyte number and area. At the intestinal level, the intervention was associated with downregulation of colonic transient receptor potential vanilloid 1 (TRPV1) gene expression, modulation of redox-associated responses, including catalase (CAT) and superoxide dismutase (SOD) expression, and differential modulation of innate immune signaling, including upregulation of Toll-like receptor 2 (TLR2) and downregulation of Toll-like receptor 4 (TLR4), together with reduced interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) expression. Collectively, these findings indicate that dietary supplementation with a capsiate-producing chili is associated with increased somatic growth and enhanced femoral development in mice, accompanied by intestinal transcriptional changes consistent with immunometabolic responses, while preserving body composition. Full article

Introduction: Simulation-based training is a key component of surgical education; however, existing models, such as dry-laboratory and virtual reality simulators, have limitations in terms of realism and accessibility. The use of human cadaveric material is also challenging because of its high cost and limited availability. Objectives: To evaluate the effectiveness of biological models based on large animal cadaveric material, specifically cattle and pigs, for practicing head and neck surgical skills. Materials and Methods: The study included 100 third- and fourth-year students, who were divided into a study group and a comparison group, with 50 participants in each group. The study group practiced surgical skills using animal cadaveric material: a porcine mandible for bone graft harvesting and a bovine head for resection craniotomy. The comparison group practiced using 3D-printed models. The results were assessed using an anonymous 8-item Likert-scale questionnaire, followed by statistical analysis using the Mann–Whitney U test. Results: In the study group, statistically significant increases were observed in satisfaction with participation, fulfillment of expectations, perceived subjective acquisition of manual skills, and overall satisfaction with the training process (p < 0.001; median scores: 38.0 and 34.0, respectively). The greatest differences were observed in satisfaction with participation, where 54% of participants rated it as “Excellent” compared with 6% in the comparison group, and in perceived subjective acquisition of manual skills, reported by 80% of participants in the study group compared with 24% in the comparison group. Conclusions. The use of cadaveric specimens from large animals is associated with higher satisfaction and represents an accessible alternative for practicing basic and commonly performed head and neck surgical procedures that do not require fine dissection of neurovascular bundles. This model provides a high degree of tactile realism and anatomical context and is subjectively preferred over non-anthropomorphic simulators. Full article

This systematic review was conducted and reported according to the PRISMA 2020 statement to synthesize evidence published between January 2020 and January 2025 on food-derived antihypertensive peptides, with emphasis on mechanisms of action, molecular stability, bioavailability, and functional food applications. PubMed, Scopus, and Web of Science were searched using combined terms related to bioactive or ACE-inhibitory peptides, stability or bioavailability, and alternative protein sources. Original peer-reviewed studies in English evaluating antihypertensive or ACE-inhibitory peptides from plant, marine, insect, fungal, dairy, or terrestrial animal matrices were considered eligible when they reported experimental evidence on activity, stability, transport, or in vivo efficacy. Three reviewers independently screened records and extracted data. A total of 177 studies were included. Plant and marine matrices accounted for approximately 72% of the evidence base, with a strong focus on low-molecular-weight peptides (<3 kDa) and multistage validation pipelines integrating in silico screening, in vitro enzymatic assays, Caco-2 transport models, ex vivo assays, and spontaneously hypertensive rat studies. Overall, the evidence supports the antihypertensive potential of selected food-derived peptides, particularly through ACE inhibition and related vascular mechanisms. Encapsulation and advanced delivery approaches improved peptide stability and bioavailability in several studies. Food-derived antihypertensive peptides represent promising candidates for functional foods and nutraceuticals; however, greater methodological standardization, formal risk-of-bias assessment in primary studies, and well-designed human trials remain necessary to strengthen translation into practice. Full article

The environmental burden from cosmetic production has intensified interest in sustainable and scientifically robust raw materials. Among the emerging alternatives, agro-industrial residues are gaining attention as chemically rich sources of bioactive compounds with potential for dermocosmetic applications. However, research on their molecular activity, formulation performance, and industrial feasibility remains fragmented across the fields of sustainability, dermatology, and engineering. This narrative review synthesizes current knowledge on the phytochemical composition of extracts from agro-residues. It also critically examines their effects on key skin-related pathways, including oxidative stress modulation, extracellular matrix regulation, inflammation, senescence, and barrier function. Compounds such as polyphenols, carotenoids, peptides, and polysaccharides have been reported to influence signaling networks, including Nrf2/ARE, NF-κB, TGF-β/Smad, and PI3K/AKT/mTOR. Importantly, most of this evidence originates from in vitro and ex vivo studies on animal models, while controlled human and clinical studies remain limited; thus, mechanistic findings should not be equated with proven dermocosmetic efficacy. Nevertheless, challenges remain, such as compositional variability, safety-validation requirements, limited skin bioavailability and stability of bioactives in finished formulations, and limitations in scalable green extraction. Economic modeling and life-cycle assessment also highlight the need to verify both financial and environmental viability. Advancing agro-residue-derived bioactives toward mainstream cosmetic use will require strategies that integrate molecular characterization, regulatory alignment, rigorous claims substantiation and sustainable process optimization. Full article

Background: This study investigates a novel alginate–gelatin hydrogel incorporating polyphenol-rich grape skin extract as a multifunctional therapeutic system for diabetic wound healing. The extract was obtained by ultrasound-assisted extraction and formulated into a biopolymer hydrogel designed to combine optimal moisture retention with the controlled release of bioactive compounds. Methods: A streptozotocin-induced diabetic rat model was used to evaluate wound contraction, collagen deposition, oxidative stress parameters, and systemic inflammatory markers over a 15-day period. Animals were assigned to four groups: untreated control, silver sulfadiazine (SSD), empty hydrogel (EH), and extract-loaded hydrogel (LH). Results: The LH formulation demonstrated superior wound closure, reaching 97.1% by day 15, significantly outperforming SSD and other groups. Hydroxyproline levels were markedly elevated in LH-treated tissues, indicating enhanced collagen synthesis and extracellular matrix formation. Redox analyses revealed substantial reductions in TBARS and significant increases in SOD, CAT, and GSH, confirming the strong antioxidative activity of the incorporated extract. Moreover, LH treatment produced pronounced decreases in IL-6 and TNF-α, restoring inflammatory balance and facilitating timely progression from the inflammatory to proliferative phase. Conclusions: These effects are attributed to the synergistic actions of grape skin polyphenols which exerted broad biochemical and structural benefits essential for diabetic wound repair. Overall, this sustainable, bioactive hydrogel represents a promising alternative for advanced wound care. Full article

Background/Objectives: Thermal injuries represent a significant global health burden, often complicated by hypertrophic scarring, chronic inflammation, and delayed re-epithelialization. While Mesenchymal Stem Cell (MSC) transplantation has shown promise, its clinical translation is hindered by risks of tumorigenicity and immunological concerns. This study evaluates the efficacy of cell-free Extracellular Vesicle (EV) therapy—derived from both mammalian MSCs and plant sources (PDNVs)—as standardized, off-the-shelf alternatives. This study synthesizes evidence focusing on re-epithelialization velocity, angiogenic activity, and anti-fibrotic outcomes, while assessing the impact of second-generation delivery scaffolds on therapeutic durability. Methods: Conducted in accordance with PRISMA 2020 guidelines and registered in PROSPERO (CRD420261305379), this review interrogated PubMed, Scopus, Embase, and Web of Science for studies published between 2015 and 2026. Eligible studies included in vivo animal models of thermal injury using purified vesicles from mammalian MSC sources or plant-derived nanovesicles compared with placebo, standard care, or untreated controls. Data were synthesized narratively; methodological quality was appraised using the SYRCLE risk of bias tool and compliance with MISEV guidelines. Results: Synthesis of 50 studies revealed that vesicle-based interventions consistently accelerate wound closure and improve histological healing. Mammalian ADSC-derived vesicles demonstrated superior anti-fibrotic effects via the miR-192-5p and miR-125b-5p axes, while hUC-MSC vesicles attenuated systemic inflammatory signaling via miR-181c. Plant-derived nanovesicles (PDNVs) showed potent antioxidant and re-epithelialization effects, with emerging potential as engineered genetic carriers. Crucially, advanced delivery systems, including bioactive hydrogels and microneedle patches, were repeatedly associated with improved local retention and more durable effects than bolus injections. Conclusions: Vesicle-based therapies show consistent pro-healing signals in preclinical models, suggesting source-dependent profiles: MSC-derived vesicles excel in immunomodulation and anti-fibrotic remodeling, while PDNVs provide a scalable, low-immunogenicity platform. As a cell-free strategy, these therapies circumvent the safety risks of live cell transplantation. This review identifies a critical shift toward second-generation delivery scaffolds to overcome the clearance crisis of topical applications, emphasizing the need for harmonized MISEV-aligned characterization in future clinical translation. Full article

Background: The emergence of multidrug-resistant (MDR) Gram-negative pathogens, namely Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii and Helicobacter pylori, necessitates urgent therapeutic alternatives. This scoping review aimed to summarize the current evidence on the efficacy of lytic bacteriophages against these critical MDR pathogens, and to identify existing research gaps and implementation challenges. Methods: The literature search was conducted by searching PubMed, Web of Science, and Scopus AI for studies published from 2015 to 2025. The inclusion criteria focused on experimental and human studies evaluating phage therapy against MDR, extensively drug-resistant (XDR), or pan-drug-resistant (PDR) strains in the four target species. A total of 172 articles were included. Results: A number of studies showed an increasing trend (2015–2025), focusing mainly on K. pneumoniae (n = 65), P. aeruginosa (n = 55), and A. baumannii (n = 48). No eligible studies for MDR H. pylori were found. All 172 studies confirmed lytic activity, with phage cocktails showing superior antibacterial activity than single phages in four studies. Phages also demonstrated antibiofilm activity (n = 44). Most animal studies reported successful bacterial reduction in animals treated with phages, and 87.5% of 23 human case studies reported patient improvement or infection clearance. However, heterogeneity in the types of animal models used and in dosage and administration routes in human studies was notable. Conclusions: Lytic bacteriophages exhibit strong potential as a new therapeutic option. Key challenges include the lack of data for MDR H. pylori, heterogeneity in animal models, and a paucity of large-scale human clinical trials. Future research must prioritize standardization, mechanistic studies, and conducting robust human trials to enable clinical translation and regulatory acceptance. Full article

The agriculture and food processing sectors are essential, meeting the fundamental needs of global populations. However, it is crucial to adopt sustainable practices that fulfill these needs while minimizing environmental impact. Climate change, once a theoretical concern, is now an urgent and tangible challenge, requiring immediate action to mitigate its effects. As such, all human activities, particularly those in resource-intensive sectors like agriculture, must be reevaluated. This study explores and reviews the potential of applying waterjet systems and their evolution in agricultural and food processes to improve efficiency and minimize resource consumption; while the use of pure waterjet technology for soft foods has emerged as an established practice, its extension to agricultural applications and the use of abrasive waterjet in this field are still in the research and experimentation phase. This work presents preliminary results, discussing the key waterjet components, their economical modeling, and food safety. Three main categories of applications—cutting of soft, plant-based products, cutting of animal products, and in-field agricultural applications—are reviewed, with detailed use cases on strawberry de-calyxing, meat–bone cutting and sugarcane harvesting, respectively. These applications are analyzed by highlighting waterjet main advantages in terms of cutting performance, as well as food quality and preservation. At the end, future directions are delineated, suggesting potential advancements that could allow us to replace traditional methods with more innovative and sustainable alternatives. A specific focus is given to abrasive ice waterjets. Full article

Bone is a hierarchically organized composite material with unique mechanical properties and an intrinsic regenerative capacity that conventional repair strategies, including autografts, allografts, xenografts, and metallic or ceramic implants, fail to fully replicate due to donor scarcity, immunogenicity, mechanical mismatch, and poor long-term integration. Bone tissue engineering (TE) offers a biologically informed alternative by integrating osteoconductive scaffolds, osteogenic progenitor cells, and osteoinductive signaling molecules into a unified regenerative framework. Unlike existing reviews that evaluate these components in isolation, this review provides a mechanistically integrated analysis that repositions scaffold design as a biologically instructive platform whose topography, stiffness, porosity, and surface chemistry collectively govern cell adhesion, mechanotransduction, osteogenic differentiation, and extracellular matrix remodeling. Critically, it moves beyond cataloging materials and fabrication approaches to evaluate how specific scaffold features drive biological outcomes and to identify frequently understated limitations, including polymer-ceramic degradation kinetics and the inadequacy of small-animal models for clinical translation. By synthesizing advances in biomaterials, additive manufacturing, and smart scaffold technologies within this integrative framework, this review provides researchers and clinicians with a structured framework for evaluating emerging strategies and prioritizing future directions in functional bone regeneration. Full article

Diarrhea is a common gastrointestinal disorder in animals, often worsened by antibiotic use. Pulsatilla chinensis (PC) is traditionally used for gastrointestinal issues, but its bioactive constituents and mechanisms remain unclear. This study investigated the preventive effects of PC in a canine model of antibiotic-associated diarrhea using an integrated multi-omics approach. LC–MS identified key constituents of PC, including anemoside B4, berberine, stigmasterol, and quercetin. In silico analyses predicted that stigmasterol and quercetin target EGFR and AKT1, modulating inflammation and epithelial repair via PI3K–Akt and IL-17 signaling pathways. In vivo, treatment with PC significantly reduced serum pro-inflammatory cytokines such as TNF-α and IL-6 and elevated immune markers including IgG and IgA compared to the control group. Furthermore, 16S rRNA analysis revealed that PC restored gut microbial diversity, reflected by increased Sobs and Chao1 indices, enriched beneficial Lactobacillus, and decreased the abundance of inflammation-associated taxa such as Proteobacteria, Desulfobacterota, and Escherichia-Shigella. These findings suggest that PC suppresses inflammation and remodels the gut microbiome, providing a mechanistic basis for its use as an herbal alternative to antibiotics. Future studies should include fecal microbiota transplantation and targeted metabolomics to establish causality and optimize therapeutic strategies. Full article

Galectins are a functionally diverse family of β-galactosyl-binding lectins that are ubiquitously present in animal species, with key roles in development and immune regulation. Recently, galectins have been found to recognize microbial glycosylated moieties, but the detailed mechanisms of their innate immune functions in mucosal epithelia have remained elusive. The zebrafish (Danio rerio) represents an ideal genetically tractable model to address these questions, as the skin, gills, and gut display mucosal surfaces exposed to the environment. In this study, we investigated the range of endogenous and microbial glycans that are recognized by zebrafish galectin Drgal1 present in epidermal mucus, which would be consistent with defense functions against a bacterial challenge. Results revealed that zebrafish galectin isoform Drgal1-L2 can recognize selected bacterial glycans, as well as zebrafish mucus glycans and cell-surface receptors for bacterial adhesins such as fibronectin (K_D = 1.593 × 10⁻⁶ M) and CD147 (K_D = 1.115 × 10⁻⁶ M). Furthermore, preliminary experiments revealed that Drgal1-L2 may hinder bacterial adhesion to epidermal mucus in about 50% at 2.5 μg/mL. Our results suggest that Drgal1-L2 present in epidermal mucus can prevent access of pathogenic bacteria to the epithelial cell surface by alternate or synergic binding to bacterial glycans and to zebrafish mucus components and epithelial receptors for bacterial adhesins. Thus, the present study provides key information for the testing of the abovementioned hypothesis by implementing gene-silencing approaches targeting both zebrafish Drgal1-L2 and its ligands. Full article